Article Text
Articles
Money, money, money
Statistics from Altmetric.com
In 2009, around £73.5million was spent on the lipid-regulating drug ezetimibe in England (plus around another £10million on the combination product simvastatin plus ezetimibe) out of a total primary care prescribing spend of £8.5billion. By comparison, just £10million was spent on the drug in 2004. This increase (mirrored throughout the UK) contrasts with a fall in overall expenditure …